Jane Street’s CONMED CNMD Stock Holding History

Jane Street’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$389K	Sell	11,900 -2,000	-14%	-$72K	﹤0.01%	8601
2026 Q1	$492K	Buy	+13,900	New	+$566K	﹤0.01%	8077
2023 Q4	–	Sell	-20,000	Closed	-$2.02M	–	9240
2023 Q3	$2.02M	Sell	20,000 -84,200	-81%	-$9.67M	﹤0.01%	4044
2023 Q2	$14.2M	Buy	104,200 +78,600	+307%	+$9.6M	﹤0.01%	1545
2023 Q1	$2.66M	Sell	25,600 -14,800	-37%	-$1.43M	﹤0.01%	3354
2022 Q4	$3.58M	Buy	40,400 +26,800	+197%	+$2.22M	﹤0.01%	2956
2022 Q3	$1.09M	Buy	13,600 +3,500	+35%	+$330K	﹤0.01%	5260
2022 Q2	$967K	Sell	10,100 -2,400	-19%	-$288K	﹤0.01%	5538
2022 Q1	$1.86M	Buy	12,500 +5,600	+81%	+$782K	﹤0.01%	4893
2021 Q4	$978K	Buy	6,900 +700	+11%	+$99.1K	﹤0.01%	5947
2021 Q3	$811K	Buy	6,200 +1,700	+38%	+$222K	﹤0.01%	6331
2021 Q2	$618K	Buy	+4,500	New	+$616K	﹤0.01%	6842

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Jane Street's CNMD Position: Q2 2026 in Review

Jane Street increased its CONMED (CNMD) stake by 28% in Q2 2026, buying an estimated $992K and bringing the position to 124,476 shares worth $4.07M. The position accounts for ﹤0.01% of the portfolio, ranked #4008.

Jane Street first reported a position in CNMD in Q1 2020 and has held it in 25 quarters since. The position peaked at $11.2M in Q4 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Jane Street held 124,476 shares of CONMED worth $4.07M as of Q2 2026.
Jane Street bought 27,553 CONMED shares in Q2 2026, an estimated $992K.
CONMED made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4008 holding.
Jane Street first reported a position in CONMED in Q1 2020 and has held it in 25 quarters since.
Jane Street's CONMED position peaked at $11.2M in Q4 2025.
246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.